Bruce S. Morra
Directeur/Membre du Conseil chez BioPharm Solutions, Inc.
Profil
Dr. Bruce S.
Morra is a Director at Medisys Technologies, Inc. He is on the Board of Directors at Medisys Technologies, Inc., BioPharm Solutions, Inc., and SoluBest Ltd.
Dr. Morra was previously employed as President & Chief Executive Officer by SCOLR Pharma, Inc., President by West Drug Delivery Systems, Chief Business Officer by Progenitor Cell Therapy LLC, a Director, Chief Business Officer & EVP by Polygenetics International, Inc., Executive Vice President & Chief Business Officer by Biopure Corp., President, Chief Operating & Financial Officer by Flamel Technologies SA, and President by ISP Filters, Inc. He also served on the board at Unigene Laboratories, Inc. and Informedix Holdings, Inc.
He received his undergraduate degree from Princeton University, a graduate degree from the University of Massachusetts, an MBA from the University of Massachusetts, and a doctorate degree from the University of Massachusetts.
Postes actifs de Bruce S. Morra
| Sociétés | Poste | Début |
|---|---|---|
| BioPharm Solutions, Inc. | Directeur/Membre du Conseil | - |
SoluBest Ltd.
 SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | Directeur/Membre du Conseil | - |
Anciens postes connus de Bruce S. Morra
| Sociétés | Poste | Fin |
|---|---|---|
| SCOLR PHARMA INC. | President | 28/08/2009 |
| West Drug Delivery Systems | President | 01/12/2004 |
| Polygenetics International, Inc. | Directeur/Membre du Conseil | 01/01/2004 |
Biopure Corp.
 Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2004 |
| UNIGENE LABORATORIES INC | Directeur/Membre du Conseil | 01/01/2003 |
Formation de Bruce S. Morra
| Princeton University | Undergraduate Degree |
| University of Massachusetts | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
| BioPharm Solutions, Inc. | |
SCOLR Pharma, Inc.
 SCOLR Pharma, Inc. Pharmaceuticals: MajorHealth Technology SCOLR Pharma, Inc. is a pharmaceutical company, engages in proprietary and patented Controlled Delivery Technology platforms to develop and commercialize novel prescription, over-the-counter and nutritional products. The company's technology is used to develop dietary supplement products, including combinations of glucosamine and chondroitin, niacin, calcium, and other dietary products. Its lead product candidate is a CDT-based extended release formulation of ibuprofen, an analgesic typically used for the treatment of pain, fever and inflammation. SCOLR Pharma was founded in 1983 and is headquartered in Bellevue, WA. | Health Technology |
Informedix Holdings, Inc.
 Informedix Holdings, Inc. Medical SpecialtiesHealth Technology InforMedix Holdings, Inc. develops integrated portable patient monitoring units, hardware, software and networked communications system to enable consumers, pharmacists, health plans, disease management organizations, pharmaceutical and biomedical companies, medical researchers and physicians to monitor and manage patients' medication adherence and clinical response. The company was founded on January 19, 2000 is headquartered in Rockville, MD. | Health Technology |
| West Drug Delivery Systems | |
| Polygenetics International, Inc. | |
Unigene Laboratories, Inc.
 Unigene Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Unigene Laboratories, Inc. was a biopharmaceutical company, which engaged in the designing, delivering, manufacturing and development of peptide-based therapeutics. The company was founded by Jay Levy, Ronald S. Levy and Warren P. Levy on October 31, 1980 and was headquartered in Boonton, NJ. | Health Technology |
Minaris Regenerative Medicine LLC
 Minaris Regenerative Medicine LLC Medical/Nursing ServicesHealth Services Minaris Regenerative Medicine LLC provides cell therapy services. It provides contract development and manufacturing organization (CDMO) services at current Good Manufacturing Practices (cGMP) standards, including clinical manufacturing, commercial manufacturing, and manufacturing development. The company was founded by Robert A. Preti and Andrew L. Pecora in 1997 and is headquartered in Allendale, NJ. | Health Services |
| ISP Filters, Inc. | Producer Manufacturing |
Biopure Corp.
Biopure Corp. Pharmaceuticals: MajorHealth Technology Biopure Corp. developed, manufactured and marketed oxygen therapeutics, a new class of pharmaceuticals that are administered intravenously to increase oxygen transport to the body's tissues. The company used patented and proprietary technology to develop and manufacture two products: Hemopure for human use, and Oxyglobin for veterinary use. It has developed Hemopure for the treatment of patients with cardiovascular ischemia. Oxyglobin, its veterinary product treated anemia in dogs, is the only oxygen therapeutic approved by the U.S. Food and Drug Administration and the European Commission. Biopure was founded in 1984 and was headquartered in Cambridge, MA. | Health Technology |
Medisys Technologies, Inc.
 Medisys Technologies, Inc. Medical SpecialtiesHealth Technology Medisys Technologies, Inc. engages in the design and development of products that address concerns about safety. The company was founded by William David Kiesel, Edward P. Sutherland, Robert L. diBenedetto and Gary Alexander on March 17, 1983 and is headquartered in Baton Rouge, LA. | Health Technology |
Flamel Technologies SA
 Flamel Technologies SA Pharmaceuticals: MajorHealth Technology Flamel Technologies SA engages in the research, development and commercialization of pharmaceutical products. Its portfolio includes Bloxiverz, Vazculep, Micropump, LiquiTime, Trigger Lock and Medusa. The company was founded by Gérard Soula in August 1990 and is headquartered in Vénissieux, France. | Health Technology |
SoluBest Ltd.
SoluBest Ltd. Pharmaceuticals: MajorHealth Technology SoluBest Ltd. develops proprietary nano-transport drug systems. Its products include fenofibrate, albendazole, resveratrol and testosterone undecanoate. The company was founded in 2001 and is headquartered in Ness Ziona, Isreal. | Health Technology |